Botanical species · safety record

Peperomia pellucida

The EFSA Compendium of Botanicals holds 12 constituent measurements for Peperomia pellucida. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Peperomia pellucida (L.) Kunth

12Constituent measurements
0Safety records
6Cited sources
0Licensed products (Canada)

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

  • Dillapiole3
  • Lignans2
  • Apiole1
  • Asarinin1
  • Camphor1
  • Isoquinoline alkaloids1
  • Saponins1
  • Tannins1
  • Tropane alkaloids1

Plant parts

  • Aerial part of plants12

Preparations

  • Solvent extraction7
  • Essential oil4
  • Drying (dehydration)1

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
ApioleAerial part of plantsEssential oil1.83 Percent AreaGC-MSResolve DOI
AsarininAerial part of plantsSolvent extractionNuclear Magnetic Resonance (NMR)Resolve DOI
CamphorAerial part of plantsDrying (dehydration)≤ 2.8 Percent AreaGC-MSResolve DOI
DillapioleAerial part of plantsEssential oil39.7 Percent AreaGC-MSResolve DOI
DillapioleAerial part of plantsEssential oil28.03 Percent AreaGC-MSResolve DOI
LignansAerial part of plantsSolvent extractionNuclear Magnetic Resonance (NMR)Resolve DOI
DillapioleAerial part of plantsEssential oil55.3 Percent AreaGC-MSNo resolvable identifier
Isoquinoline alkaloidsAerial part of plantsSolvent extractionPhytochemical screeningNo resolvable identifier
LignansAerial part of plantsSolvent extractionStandard Chromatographic tests (paper- thin layer- and column chromatography)No resolvable identifier
SaponinsAerial part of plantsSolvent extractionPhytochemical screeningNo resolvable identifier
TanninsAerial part of plantsSolvent extractionPhytochemical screeningNo resolvable identifier
Tropane alkaloidsAerial part of plantsSolvent extractionPhytochemical screeningNo resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. Gini, T.G., Jothi, G.J. Preliminary phytochemical screening of whole plant extracts of peperomia pellucida (linn.) HBK (piperaceae) and marsilea quadrifolia linn. (marsileaceae). International Journal of Pharmacognosy and Phytochemical Research, 2013, vol. 5, no. 3, p. 200-214.
  2. De Lira, P.N.B., Da Silva, J.K.R., Andrade, E.H.A., Sousa, P.J.C., Silva, N.N.S., Maia, J.G.S. Essential oil composition of three Peperomia species from the Amazon, Brazil. Natural product communications, 2009, vol. 4, no. 3, p. 427-430.
  3. da Silva, MHL., Zoghbi, MDB., Andrade, EHA., Maia, JGS. The essential oils of Peperomia pellucida Kunth and P. circinnata Link var. circinnata . Flavour and fragrance journal, 1999, vol. 14, no. 5, p. 312-314. DOI
  4. Verma, Ram S., Padalia, Rajendra C., Goswami, Prakash., Chauhan, Amit. Essential oil composition of Peperomia pellucida (L.) Kunth from India. JOURNAL OF ESSENTIAL OIL RESEARCH, 2015, vol. 27, no. 2, p. 89-95. DOI
  5. Xu, S., Li, N., Ning, MM., Zhou, CH., Yang, QR., Wang, MW. Bioactive compounds from Peperomia pellucida. Journal of natural products, 2006, vol. 69, no. 2, p. 247-250. DOI
  6. Bayma, JD., Arruda, MSP., Muller, AH., Arruda, AC., Canto, WC. A dimeric ArC2 compound from Peperomia pellucida. PHYTOCHEMISTRY, 2000, vol. 55, no. 7, p. 779-782.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue